GATA2 and prostate neoplasm: Importantly, GATA2 overexpression in prostate tumor has been associated with increased motility and invasiveness, proliferation, tumorigenicity, and chemoresistance (Rodriguez-Bravo et al., 2017), whereas in PDAC it was found increased in high-grade tumors and cell lines (Diaferia et al., 2016).